Display Settings:

Format

Send to:

Choose Destination
Pharmacogenomics. 2014 Apr;15(6):719-22. doi: 10.2217/pgs.14.18.

Warfarin pharmacogenetic trials: is there a future for pharmacogenetic-guided dosing?

Author information

  • 1Department of Genetics & Genomic Sciences, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1497, New York, NY 10029, USA.

KEYWORDS:

CYP2C9; VKORC1; clinical utility; pharmacogenetics; pharmacogenomics; randomized controlled clinical trial; warfarin

PMID:
24897277
[PubMed - in process]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Atypon
    Loading ...
    Write to the Help Desk